Skip to content

Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring

Diabetes Care Transformation: Diabetes Data Registry and Intensive Remote Monitoring

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02596204
Acronym
DCT1A
Enrollment
113
Registered
2015-11-04
Start date
2015-09-30
Completion date
2016-12-31
Last updated
2017-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Brief summary

With emerging mobile technology, sharing glucose, insulin and sensor data with the clinic for frequent and timely monitoring is now feasible. The investigators propose to leverage this new technology to provide children and families with appropriate interventions to help manage their diabetes.

Detailed description

The investigators will collect insulin dosing via pump records, blood glucose meter, continuous glucose sensor, activity, heart rate, and sleep data on a weekly basis from 100 children with diabetes. The investigators hypothesize that with the collection and analysis of insulin, blood glucose, sensor, activity, heart rate and sleep data in children with diabetes the investigators can identify glucose patterns and predictors of acute events. The 100 children will be randomized to either conventional therapy (data upload group) or intensive remote therapy (weekly review group). Conventional therapy will consist of routine quarterly visits to the clinic and as-needed communication with the diabetes staff, initiated by the family, between study visits. Intensive remote therapy will consist of routine quarterly visits to the clinic along with weekly remote review of insulin and blood glucose data by the research staff, and additional communication with the family, initiated by the diabetes staff as needed, between visits. The investigators hypothesize that with weekly, manual review of real-time insulin, glucose, and activity data in children with diabetes, and recommended regimen changes based on the data, the investigators will be able to lower HbA1c values in children in the weekly review group as compared to children in the data upload group.

Interventions

Subjects will wear a FitBit activity monitor and continue to use their insulin pump. Fitbit, pump and sensor (if applicable) data will be uploaded at least weekly. For subjects in the weekly review group, research staff (CDE, NP and/or MD) will review uploaded blood glucose, pump, and available sensor, activity and sleep data on a weekly basis. If glucose patterns are identified which suggest a change to diabetes management (ie insulin dose changes), the family will be contacted by text, email or telephone to review glucose patterns and to review staff recommendations.

DEVICEFitBit

All subjects will wear a FitBit activity monitor.

Sponsors

UnitedHealth Group
CollaboratorINDUSTRY
Children's Hospitals and Clinics of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

1. Type 1 diabetes, using an insulin pump (Medtronic, Omnipod, Animas) 2. Duration of diabetes \>1 year 3. Age: 8-17 years of age, inclusive. 4. Hemoglobin A1c 8.0-10.0% at baseline visit, inclusive. 5. Seen in the McNeely Diabetes Clinic within the past 6 months. 6. The family/child is testing blood glucose at least 4 times a day. 7. The family has a smart phone and service.

Exclusion criteria

1. The child is not using insulin for management of diabetes. 2. The child uses multiple daily injections of insulin. 3. The child is unwilling to use the wearable device, or the family is unwilling or unable to upload glucose and insulin data on a routine basis 4. The family is unwilling or unable to upload data from devices such as meter, pump, sensor, wearable device. 5. Diagnosis of a mental health disorder. 6. Parent/child does not speak English as the device software is only available in English.

Design outcomes

Primary

MeasureTime frameDescription
Change in Hemoglobin A1cFrom baseline to 6 monthsChange in HbA1c from baseline to 6 months

Secondary

MeasureTime frameDescription
PedsQL Inventory (PedsQL)6 monthsThe investigators will assess change in the PedsQL (Peds Quality of Life) Inventory from baseline to 6 months between data upload and weekly review groups.
Diabetes Family Conflict Scale (DFCS)6 monthsThe investigators will assess change in the Diabetes Family Conflict Scale from baseline to 6 months between data upload and weekly review groups.
Health care utilization6 monthsThe investigators will track the number of phone calls to clinic, emergency department visits and hospitalizations over 6 months between data upload and weekly review groups
Problem Areas in Diabetes (PAID) survey6 monthsThe investigators will assess change in the Problem Areas in Diabetes- pediatrics and Problem Areas in Diabetes- parent from baseline to 6 months between data upload and weekly review groups.
Change in Hemoglobin A1cChange from 6 months to 9 monthsChange in hemoglobin A1c from 6 months (end of active intervention) to 9 months
Center for Epidemiology Scale- Depression (CES-D) survey6 monthsThe investigators will assess change in the Center for Epidemiology Scale- Depression from baseline to 6 months between data upload and weekly review groups.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026